Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$739,239.00
Oct 1, 2013
Mechanisms of Protection and Informed Target Discovery for Gene and Stem Cell Therapy in Sepsis
$150,000.00
Sep 1, 2016
"Kill-switch" enabled, immune-silent, non-cytopathic, and persistent paramyxovirus vector for respiratory gene therapy.
$165,000.00
Apr 1, 2021
Government
Building genomic resources for climate smart potato to address sustainable development goals (SDGs)
ICP-2021-22-AN-10
The objective of this project is fund the use of transcriptome sequencing to develop resources to identify genes and advance tools to mine DNA sequences of wild Solanum species, landraces and cultivars in the Centro International de la Papa genebank for genetic variation associated with improving traits related to sustainable development goals.
$100,000.00
May 1, 2011
AAV-Mediated Inclusion Formation as a Novel Gene Therapy Strategy for the Assessment and Treatment of ALS
$3,522,703.00
Jun 1, 2020
For-profit organization
Biomanufacturing Centre Project.
815823
This project aimed to establish Canada’s first end-to-end manufacturing of genetic medicines for the production of nanomedicine-based RNA vaccines, gene therapies and cell therapies.
$5,000.00
May 1, 2018
Controlled gene editing with the TevSaCas9 dual nuclease system as a potential therapy for Duchenne muscular dystrophy
$375,000.00
Apr 1, 2022
For-profit organization
Neurological, ocular and bone-marrow gene targeting therapy applications
988559
The project will involve the development of expanded Huntington's Disease gene therapy strategies, addition of retinal and bone marrow targeting capabilities, and demonstration of the delivery of alternate gene editing cargos.
$205,000.00
Jul 1, 2012
Targeting the loss of the von Hippel-Lindau tumor suppressor gene at a late-stage of autophagy for the development of anticancer therapy
$554,057.00
Oct 1, 2013
Clonal evolution of medulloblastoma BTICs (brain tumor initiating cells) in response to therapy: Discovering the refractory BTIC population through genes regulating stem cell self-renewal
$1,063,350.00
Apr 1, 2018
Characterization of HR-Killer1 and identification of small molecules for cancer therapy and enhanced gene editing using CRISPR/Cas9-based DNA repair strategies